NASDAQ: PTCT · Life Sciences · 10 alerts · CIK 1070081
Share price
$60.97Close, Nov 16
Market cap
$5.09B
Shares outstanding
83.54MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All PTC Therapeutics, Inc. filings on SEC EDGAR ↗
PTC Therapeutics Director Michael Schmertzler Sells $149K of Stock
Michael Schmertzler, Director, sold 2,500 shares of PTC Therapeutics, Inc. at $59.52 to $60.14 a share (average $59.61) in 2 transactions, worth $149K in total on Oct 14, 2026. Shares held after the trade: 1,291,594 (-0.0%).
PTC Therapeutics Exec. VP and CLO Mark Elliott Boulding Sells $12.3K of Stock
Mark Elliott Boulding, Exec. VP and CLO, sold 192 shares of PTC Therapeutics, Inc. at $64.26 a share, worth $12.3K in total on Oct 9, 2026. Shares held after the trade: 105,272 (-0.2%).
PTC Therapeutics Director Michael Schmertzler Sells $155K of Stock
Michael Schmertzler, Director, sold 2,447 shares of PTC Therapeutics, Inc. at $63.38 a share, worth $155K in total on Oct 7, 2026. Shares held after the trade: 1,294,147 (-0.2%).
PTC Therapeutics Exec. VP and CLO Mark Elliott Boulding Sells $133K of Stock
Mark Elliott Boulding, Exec. VP and CLO, sold 2,073 shares of PTC Therapeutics, Inc. at $64.03 to $64.16 a share (average $64.06) in 2 transactions, worth $133K in total between Oct 5, 2026 and Oct 6, 2026. Shares held after the trade: 105,272 (-0.4%).
PTC Therapeutics Director Glenn Steele Jr. Md. Phd. Sells $782K of Stock
Glenn Steele Jr. Md. Phd., Director, sold 12,000 shares of PTC Therapeutics, Inc. at $65.16 a share, worth $782K in total on Sep 30, 2026. Shares held after the trade: 22,500 (-34.8%).
PTC Therapeutics Director Michael Schmertzler Sells $1.35M of Stock
Michael Schmertzler, Director, sold 20,000 shares of PTC Therapeutics, Inc. at $66.58 to $68.45 a share (average $67.49) in 4 transactions, worth $1.35M in total between Sep 16, 2026 and Sep 17, 2026. Shares held after the trade: 1,296,594 (-0.0%).